This study investigates the use of N-acetylcysteine (NAC) as a potential neuroprotective treatment for Parkinson's disease (PD) through a randomized, double-blind, placebo-controlled trial. The study found that NAC supplementation led to modest improvements in motor function and reduced oxidative stress markers in patients with PD. NAC is thought to act
